Found 4 matching trials
Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children
PHASE3The purpose of this study is to examine the efficacy and safety of Eslicarb...
Location
Ambulanz für Neuropädiatrie und Entwicklungsdiagnostik, Med. Univ. Graz
Efficacy and Safety Study of BIA 2-093 in Combination With Other Anti-Epileptic Drugs to Treat Partial Epilepsy
PHASE3The primary objective of the study is to evaluate the efficacy of eslicarba...
Location
Bial - Portela & Cª, S.A.
Efficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial Epilepsy
PHASE3The primary objective was to evaluate the efficacy of eslicarbazepine aceta...
Location
Bial - Portela & Cª, S.A.
Efficacy, Safety, and Tolerability of Eslicarbazepine Acetate in the Recurrence Prevention of Bipolar I Disorder
PHASE2This was an extension study consisting of 2 parts. In Part I, all participa...
Location
Multiple Locations